Your browser doesn't support javascript.
Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19.
Liu, Qiang; Huang, Na; Li, Anni; Zhou, Yuanhong; Liang, Liang; Song, Xinyu; Yang, Zhanqiu; Zhou, Xiaolin.
  • Liu Q; Department of Infectious Disease, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang.
  • Huang N; Department of Infectious Disease, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang.
  • Li A; Department of Infectious Disease, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang.
  • Zhou Y; Department of Infectious Disease, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang.
  • Liang L; Department of Infectious Disease, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang.
  • Song X; Department of Infectious Disease, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang.
  • Yang Z; State Key Laboratory of Virology, Institute of Medical Virology, School of Medicine, Wuhan University, Wuhan, Hubei, China.
  • Zhou X; Department of Infectious Disease, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang.
Medicine (Baltimore) ; 100(6): e24544, 2021 Feb 12.
Article in English | MEDLINE | ID: covidwho-1082613
ABSTRACT
ABSTRACT To clarify the effect of aspirin on mortality and viral duration in adults infected with respiratory syndrome coronavirus 2 (SARS-Cov-2).After propensity score-matched (PSM) case-control analyses 24 pairs of patients were enrolled and followed up for 2 months. Both 30-day and 60-day mortality in the aspirin group were significantly lower than that in the non-aspirin group (P = .021 and P = .030, respectively). The viral duration time between the 2 groups was not significantly different (P = .942).Among adults (with hypertension, cardiovascular diseases) infected with SARS-Cov-2, low-dose aspirin medication (100 mg/day) was associated with lower risk of mortality compared with non-aspirin users.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspirin / Embolism / Fibrinolytic Agents / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Medicine (Baltimore) Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspirin / Embolism / Fibrinolytic Agents / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Medicine (Baltimore) Year: 2021 Document Type: Article